The chemical class termed LMO1 Activators encompasses a diverse range of compounds that, based on their known biological activities and mechanisms of action, are speculated to indirectly influence the activity of the LMO1 protein. LMO1, a transcription factor, plays a crucial role in various cellular processes, and its activity is intricately linked to numerous signaling pathways. The chemicals in this class are not directly interacting with LMO1 but are thought to modulate its activity through their effects on these pathways. This speculative class includes molecules like Forskolin, Ionomycin, and Phorbol 12-myristate 13-acetate (PMA), each with distinct modes of action, ranging from modulation of intracellular cAMP levels by Forskolin to altering calcium signaling as seen with Ionomycin, and activation of protein kinase C (PKC) by PMA. These varied mechanisms highlight the complex interplay between different cellular signaling pathways and transcription factors like LMO1.
Further exemplifying this complexity are compounds such as EGF, IGF-1, FGF-basic, and VEGF, which are primarily involved in growth and differentiation pathways. These molecules, although primarily known for their roles in cell growth, angiogenesis, and differentiation, might have a cascading effect on the regulatory mechanisms of LMO1. Similarly, agents like Anisomycin and Dibutyryl-cAMP, which stimulate the MAPK pathway and mimic cAMP respectively, suggest the potential of cross-talk between these signaling molecules and LMO1 activity. The inclusion of BMP-4 and Lithium Chloride, which are implicated in developmental pathways and Wnt/β-catenin signaling, underscores the broad spectrum of cellular processes that could intersect with LMO1's function. It is the indirect and complex interactions of these chemicals with cellular signaling pathways that form the basis of their speculative classification as LMO1 Activators. Each compound, through its unique influence on specific cellular pathways or processes, represents a potential avenue through which LMO1 activity could be modulated, highlighting the intricate nature of cellular signaling networks and the potential for diverse chemical entities to impact key regulatory proteins like LMO1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator, increases cAMP levels, possibly affecting pathways that intersect with LMO | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, potentially influencing calcium-dependent pathways linked to LMO | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator, might modulate signaling pathways that could intersect with LMO1's role. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Stimulates MAPK pathway, potentially affecting transcription factors like LMO | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog, can activate PKA, potentially influencing pathways intersecting with LMO | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
Cytokinin, involved in cell growth and differentiation, could influence LMO1 indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt/β-catenin signaling, potentially impacting pathways related to LMO1's function in development. | ||||||